1. Market Research
  2. > Biotechnology Market Trends
  3. > Global Biotechnology Industry Market Research & Statistics

Global Biotechnology Industry Market Research & Statistics

About 6300 reports

Download Unlimited Documents from Trusted Public Sources

Global Biotechnology Overview

  • December 2016
    14 pages
  • Biotechnology  

  • Spain  

    World  

    Europe  

View report >

Biotechnology Industry in Europe and the US

  • December 2016
    29 pages
  • Biotechnology  

  • Europe  

    United States  

    World  

View report >

Biotechnology Industry in Europe and the US - Forecast

  • July 2016
    9 pages
  • Europe  

    United States  

View report >

Global Biotechnology Industry

  • July 2016
    22 pages
  • Biotechnology  

  • World  

    North America  

View report >

Biotechnology Industry in Finland and Europe

  • June 2016
    204 pages
  • Biotechnology  

    Industrial Biot...  

    Synthetic Biolo...  

  • Finland  

    Europe  

View report >

Biotechnology Industry

  • April 2016
    44 pages
  • Biotechnology  

  • Egypt  

    China  

    Brazil  

View report >

Biotechnology Industry in Europe

  • February 2016
    29 pages
  • Biotechnology  

    Environment  

  • Europe  

    World  

    OECD  

View report >

Biotechnology Industry - Forecast

  • January 2016
    18 pages
  • Biotechnology  

  • Asia  

    Japan  

    Taiwan  

View report >

Global Biotechnology Industry

  • January 2016
    8 pages
  • Biotechnology  

    Biotechnology  

  • World  

View report >

Plant Biotechnology Industry in North America and the US - Forecast

  • January 2016
    30 pages
  • Plant Biotechno...  

    Farming  

    Corn  

  • North America  

    United States  

    World  

View report >


About 3300 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 87 - $ 6995)

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

Frontier Pharma: Hepatitis C - Diverse Range Of First-i ...

December 2016 $ 6995

Frontier Pharma: Asthma Therapeutics - Cytokine And Kin ...

November 2016 $ 6995

Sample Preparation In Genomics, Proteomics, And Epigeno ...

January 2017 $ 6650

Global Markets For Nanocomposites, Nanoparticles, Nanoc ...

January 2017 $ 6650

Biobanking: Technologies And Global Markets

November 2016 $ 6650

Cancer Vaccines: Technologies And Global Markets

November 2016 $ 6650

Bioprinting: Technologies And Global Markets

October 2016 $ 6650

Global Laboratory Products Purchasing Trends, 2016–20 ...

December 2016 $ 6000

France Diabetes Care Devices Market Outlook To 2022 - G ...

January 2017 $ 5995

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.